R. Khandia, Neerja Viswanathan, Shailja Singhal, T. Alqahtani, Mohannad A Almikhlafi, Alexander Nikolaevich Simonov, Ghulam Md Ashraf
{"title":"Ameliorative effects of phytomedicines on Alzheimer's patients.","authors":"R. Khandia, Neerja Viswanathan, Shailja Singhal, T. Alqahtani, Mohannad A Almikhlafi, Alexander Nikolaevich Simonov, Ghulam Md Ashraf","doi":"10.2174/1567205019666220610155608","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nAlzheimer's Disease (AD) is a progressive, neurodegenerative disease that severely affects affected individuals' cognitive abilities, memory, and quality of life. It affects the elderly population, and there is no permanent prevention or cures available today, treatments mainly aiming to alleviate the symptoms as and when they appear. Alternate therapeutic approaches are being researched constantly, and there is a growing focus on phytomedicine, herbal medicine, organic compounds, ayurvedic compounds for the treatment of AD.\n\n\nMETHODS\nThe current study aims to provide an extensive review of these plants against AD from the currently existing literature. Most relevant keywords like Alzheimer's Disease, phytomedicines, ethnic medicines, the role of phytomedicine in neuroprotection, common phytomedicines against AD etc., were used to select the plants and their metabolites effective in treating AD. The study focuses on six plants: Panax ginseng, Ginkgo biloba, Bacopa monnieri, Withania somnifera, Curcuma longa, and Lavandula angustifolia. Their active components have been studied alongwith, neuroprotective properties, and evidence of in-vitro, pre-clinical studies, and clinical studies conducted to prove their therapeutic potential against the disease have been presented.\n\n\nRESULTS\nAll plants envisaged in the study show potential for fighting against AD to varying degrees. Their compounds have shown therapeutic effect by reversing the neurological changes such as clearing Aβ plaque and neurofibrillary tangle formation, and ameliorative effects against neurodegeneration through processes including improving concentration, memory, cognition and learning, higher working and cue memory, improved spatial memory, inhibition of NF-κB expression, inhibiting the release of pro-inflammatory cytokines, inhibition of AChE and lipid peroxidase enzymes, and reduction of interleukin levels and tumor necrosis factor-alpha.\n\n\nCONCLUSION\nThe present review is a comprehensive and up-to-date analysis supported with the evidentiary profs from pre-clinical studies, meta-analyses, and review papers related to natural phytochemicals' impact on neurodegenerative disorders like AD.","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Alzheimer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1567205019666220610155608","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
INTRODUCTION
Alzheimer's Disease (AD) is a progressive, neurodegenerative disease that severely affects affected individuals' cognitive abilities, memory, and quality of life. It affects the elderly population, and there is no permanent prevention or cures available today, treatments mainly aiming to alleviate the symptoms as and when they appear. Alternate therapeutic approaches are being researched constantly, and there is a growing focus on phytomedicine, herbal medicine, organic compounds, ayurvedic compounds for the treatment of AD.
METHODS
The current study aims to provide an extensive review of these plants against AD from the currently existing literature. Most relevant keywords like Alzheimer's Disease, phytomedicines, ethnic medicines, the role of phytomedicine in neuroprotection, common phytomedicines against AD etc., were used to select the plants and their metabolites effective in treating AD. The study focuses on six plants: Panax ginseng, Ginkgo biloba, Bacopa monnieri, Withania somnifera, Curcuma longa, and Lavandula angustifolia. Their active components have been studied alongwith, neuroprotective properties, and evidence of in-vitro, pre-clinical studies, and clinical studies conducted to prove their therapeutic potential against the disease have been presented.
RESULTS
All plants envisaged in the study show potential for fighting against AD to varying degrees. Their compounds have shown therapeutic effect by reversing the neurological changes such as clearing Aβ plaque and neurofibrillary tangle formation, and ameliorative effects against neurodegeneration through processes including improving concentration, memory, cognition and learning, higher working and cue memory, improved spatial memory, inhibition of NF-κB expression, inhibiting the release of pro-inflammatory cytokines, inhibition of AChE and lipid peroxidase enzymes, and reduction of interleukin levels and tumor necrosis factor-alpha.
CONCLUSION
The present review is a comprehensive and up-to-date analysis supported with the evidentiary profs from pre-clinical studies, meta-analyses, and review papers related to natural phytochemicals' impact on neurodegenerative disorders like AD.
期刊介绍:
Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer''s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ''bird''s-eye view'' of the current state of Alzheimer''s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.